Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 6622 | 1391 | 36.6 | 85% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | FHIT | Author keyword | 218 | 74% | 12% | 164 |
| 2 | WWOX | Author keyword | 180 | 87% | 6% | 90 |
| 3 | COMMON FRAGILE SITES | Author keyword | 63 | 77% | 3% | 43 |
| 4 | FRAGILE HISTIDINE TRIAD | Author keyword | 58 | 88% | 2% | 28 |
| 5 | FHIT GENE | Author keyword | 58 | 80% | 3% | 36 |
| 6 | WW DOMAIN CONTAINING OXIDOREDUCTASE | Author keyword | 57 | 95% | 1% | 19 |
| 7 | FRAGILE SITES | Author keyword | 36 | 44% | 4% | 62 |
| 8 | FRA3B | Author keyword | 34 | 93% | 1% | 13 |
| 9 | WOX1 | Author keyword | 27 | 83% | 1% | 15 |
| 10 | FRAGILE SITE | Author keyword | 24 | 52% | 2% | 32 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | FHIT | 218 | 74% | 12% | 164 | Search FHIT | Search FHIT |
| 2 | WWOX | 180 | 87% | 6% | 90 | Search WWOX | Search WWOX |
| 3 | COMMON FRAGILE SITES | 63 | 77% | 3% | 43 | Search COMMON+FRAGILE+SITES | Search COMMON+FRAGILE+SITES |
| 4 | FRAGILE HISTIDINE TRIAD | 58 | 88% | 2% | 28 | Search FRAGILE+HISTIDINE+TRIAD | Search FRAGILE+HISTIDINE+TRIAD |
| 5 | FHIT GENE | 58 | 80% | 3% | 36 | Search FHIT+GENE | Search FHIT+GENE |
| 6 | WW DOMAIN CONTAINING OXIDOREDUCTASE | 57 | 95% | 1% | 19 | Search WW+DOMAIN+CONTAINING+OXIDOREDUCTASE | Search WW+DOMAIN+CONTAINING+OXIDOREDUCTASE |
| 7 | FRAGILE SITES | 36 | 44% | 4% | 62 | Search FRAGILE+SITES | Search FRAGILE+SITES |
| 8 | FRA3B | 34 | 93% | 1% | 13 | Search FRA3B | Search FRA3B |
| 9 | WOX1 | 27 | 83% | 1% | 15 | Search WOX1 | Search WOX1 |
| 10 | FRAGILE SITE | 24 | 52% | 2% | 32 | Search FRAGILE+SITE | Search FRAGILE+SITE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | 3P142 | 254 | 82% | 11% | 149 |
| 2 | FRA16D | 179 | 95% | 4% | 59 |
| 3 | FRA3B | 124 | 84% | 5% | 68 |
| 4 | DOMAIN CONTAINING OXIDOREDUCTASE | 119 | 84% | 5% | 66 |
| 5 | HISTIDINE TRIAD GENE | 73 | 88% | 3% | 35 |
| 6 | FRAGILE GENES | 69 | 96% | 2% | 22 |
| 7 | CHROMOSOMAL FRAGILE SITE | 61 | 95% | 1% | 20 |
| 8 | FHIT GENE | 57 | 40% | 8% | 111 |
| 9 | FRAGILE HISTIDINE TRIAD | 33 | 77% | 2% | 23 |
| 10 | BROAD REGION | 30 | 100% | 1% | 12 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Chromosome fragile sites | 2007 | 279 | 136 | 62% |
| WW domain-containing oxidoreductase's role in myriad cancers: Clinical significance and future implications | 2014 | 15 | 91 | 79% |
| Alteration of WWOX in human cancer, a clinical view | 2015 | 2 | 97 | 65% |
| Common fragile sites: mechanisms of instability revisited | 2012 | 80 | 76 | 39% |
| gamma delta T Cells and Their Potential for Immunotherapy | 2014 | 8 | 46 | 89% |
| The fragile site WWOX gene and the developing brain | 2015 | 1 | 16 | 94% |
| WWOX: A fragile tumor suppressor | 2015 | 1 | 88 | 90% |
| The complex basis underlying common fragile site instability in cancer | 2012 | 34 | 100 | 65% |
| Common fragile sites as targets for chromosome rearrangements | 2006 | 101 | 89 | 71% |
| WWOX, the chromosomal fragile site FRA16D spanning gene: Its role in metabolism and contribution to cancer | 2015 | 1 | 41 | 80% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | IMMUNOL CANC IMRIC | 11 | 78% | 0.5% | 7 |
| 2 | AL QUDS BARD HONORS | 6 | 80% | 0.3% | 4 |
| 3 | LAUTENBERG IMMUNOL CANC | 4 | 35% | 0.6% | 9 |
| 4 | STEM CELL REGULAT MOL HEMATOPOIESIS | 2 | 50% | 0.2% | 3 |
| 5 | MOL CANCEROGENESIS | 2 | 27% | 0.4% | 6 |
| 6 | STRUCT BIOL BIOINFORMAT PROGRAM | 1 | 31% | 0.3% | 4 |
| 7 | HOSP SANTO ANDREA | 1 | 50% | 0.1% | 2 |
| 8 | IPHB MED BIOCHEM | 1 | 100% | 0.1% | 2 |
| 9 | MED A GEMELLI IST GENET UMANA LARGO F VITO 1 | 1 | 50% | 0.1% | 2 |
| 10 | UMR 3244 | 1 | 21% | 0.4% | 5 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000115047 | RBM5//HUMAN CHROMOSOME 3//LUCA 15 |
| 2 | 0.0000082517 | AP4A//DIADENOSINE TETRAPHOSPHATE//DIADENOSINE POLYPHOSPHATES |
| 3 | 0.0000064434 | JACOBSEN SYNDROME//11Q SYNDROME//11Q TERMINAL DELETION DISORDER |
| 4 | 0.0000063158 | CHROMOSOME 3Q26//PAN RAS//HUMAN TELOMERASE GENE |
| 5 | 0.0000054999 | FRAGILE X SYNDROME//FRAGILE X//FMR1 |
| 6 | 0.0000054109 | SW MED SIMMONS CANC//COPY NUMBER LOSS//K RAS GENOTYPES |
| 7 | 0.0000050776 | JUMPING TRANSLOCATION//INTERSTITIAL TELOMERIC SEQUENCES//TELOMERE ASSOCIATION |
| 8 | 0.0000044601 | CLIN BREAST CARE PROJECT//16Q243//CHROMOSOMAL SCANNING |
| 9 | 0.0000040927 | G2 ASSAY//MUTAGEN SENSITIVITY//CHROMOSOMAL RADIOSENSITIVITY |
| 10 | 0.0000040850 | ZNF703//C8ORF4//8P12 |